Multidisciplinaire richtlijn Cardiovasculair ... - Diliguide

Koren MJ, Hunninghake DB. Clinical outcomes in managed-care patients with coronary heart
disease treated aggressively in lipid-lowering disease management clinics: the alliance
study. J Am Coll Cardiol 2004;44:1772-9.
Kotseva K, Wood D, De Backer G, De Baquer D, Pyorala K, Keil U. EUROASPIRE III: a survey
on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients
from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009;16:121-37.
Kreijl CF, Knaap AGAC, Busch MCM, Havelaar AH, Kramers PGN, Kromhout D, et al. Ons
eten gemeten. Gezonde voeding en veilig voedsel in Nederland. RIVM Rapport.
Volksgezondheid Toekomst Verkenning (2004). Bilthoven: RIVM, 2004.
Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in
achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr
Opin Cardiol 2004;19:357-62.
Kushiro T, Mizuno K, Nakaya N, Ohashi Y, Tajima N, Teramoto T, et al. Pravastatin for
cardiovascular event primary prevention in patients with mild-to-moderate hypertension in
the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese
(MEGA) Study. Hypertension 2009;53:135-41.
Kyrklund C, Backman JT, Kivisto KT, Neuvonen M, Laitila J, Neuvonen PJ. Rifampin greatly
reduces plasma simvastatin and simvastatin acid concentrations. Clin Pharmacol Ther
2000;68:592-7.
Kyrklund C, Backman JT, Neuvonen M, Neuvonen PJ. Effect of rifampicin on pravastatin
pharmacokinetics in healthy subjects. Br J Clin Pharmacol 2004;57:181-7.
Lancaster T, Stead L. Physician advice for smoking cessation. Cochrane Database Syst Rev
2004;CD000165.
LaRosa JC, Grundy SM, Waters DD, Shear C, Barter P, Fruchart JC, et al. Intensive lipid
lowering with atorvastatin in patients with stable coronary disease. N Engl J Med
2005;352:1425-35.
Latner JD. Self-help in the long-term treatment of obesity. Obes Rev 2001;2:87-97.
Latner JD, Wilson GT, Stunkard AJ, Jackson ML. Self-help and long-term behavior therapy for
obesity. Behav Res Ther 2002;40:805-12.
Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum
cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994;308:367-72.
Law MR. Plant sterol and stanol margarines and health. West J Med 2000;173:43-7.
Law MR, Wald NJ, Morris JK, Jordan RE. Value of low dose combination treatment
with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ
2003a;326:1427.
Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein
cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ
2003b;326:1423.
Lean ME, Han TS, Morrison CE. Waist circumference as a measure for indicating need for
weight management. BMJ 1995;311:158-61.
123 LITERATUUR